Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
2,751,269
-
Share change
-
-160,245
-
Total reported value
-
$11,960,000
-
Price per share
-
$4.31
-
Number of holders
-
12
-
Value change
-
-$702,624
-
Number of buys
-
1
-
Number of sells
-
8
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q3 2015
As of 30 Sep 2015,
Aptose Biosciences Inc. - Common Shares was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,751,269 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, BANK OF MONTREAL /CAN/, BVF INC/IL, BAKER BROS. ADVISORS LP, Trellus Management Company, LLC, Weiss Multi-Strategy Advisers LLC, DAFNA Capital Management LLC, ROYAL BANK OF CANADA, and Knoll Capital Management, LP.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.